INTRODUCTION
Chemokine receptors (CKRs) are a specialized subset of 7-transmembrane G-protein coupled receptors (GPCRs) that is broadly grouped into CC, CXC, CX 3 C, and C classes based on the structure of their cognate agonists (Murphy et al., 2000) . All CKRs are composed of an extracellular amino-terminal domain, seven hydrophobic transmembrane domains and a cytoplasmic carboxy-terminal tail that harbors important motifs for basal and ligand-induced signaling, desensitization, and endocytosis. CKRs transduce signals via multiple mediators, i.e. heterotrimeric G-proteins, β-arrestin, and GPCR kinases. Signal transduction following ligand binding is initiated by stabilizing the CKR in an active conformation that enables the binding and activation of heterotrimeric G-proteins (Scheer et al., 1997; Rasmussen et al., 1999; Scheer et al., 2000; Seifert and Wenzel-Seifert, 2003) . A highly conserved sequence starting with Asp-Arg-Tyr (DRY) in the second intracellular loop of all CKRs plays a critical role in mediating the binding and signaling via heterotrimeric G-proteins. Following agonistengagement, desensitization of CKRs rapidly occurs by the interaction of β-arrestin with phosphorylated Ser/Thr residues in the cytoplasmic tail of CKRs. Phosphorylation abolishes the signaling via heterotrimeric G-proteins and β-arrestin binding lowers the receptor cell surface expression by targeting the molecule for endocytosis (Krupnick and Benovic, 1998) .
In addition, some CKRs contain a di-leucine based element in their cytoplasmic tail that provides a second independent motif for receptor endocytosis. Receptor internalization, recycling and/or degradation are key mechanisms governing CKR signaling activity and are therefore regulated by diverse pathways, including clathrin-mediated endocytosis and internalization via caveolae. The basal and ligand-induced receptor internalization rate and the fate of the receptors after endocytosis depend on multiple factors that have only partially been elucidated for some CKR family members. Both processes are influenced by determinants such as the type and extracellular concentration of ligand, the presence of endocytosis motifs in the individual CKR cytoplasmic tail, the phosphorylation status of the CKR, and the cell type-specific expression pattern of adaptor molecules for endocytosis (Neel et al., 2005) .
Physiologically, CKRs regulate a variety of processes involving leukocytes, including inflammatory responses, chemotaxis, as well as angiogenesis (Rossi and Zlotnik, 2000; Johnson et al., 2004; Esche et al., 2005) . However, CKRs and GPCRs have also been implicated in viral disease processes: herpesviruses and poxviruses encode for proteins that are homologous to cellular GPCR ligands or specifically modulate the expression of host cell CKRs (Sodhi et al., 2004) . Some DNA viruses even support their own replication by encoding for proteins that are homologous to cellular CKRs, but mediate altered signal transduction in response to host chemokines. Moreover, primate lentiviruses typically engage a specific CKR, in conjunction with CD4, for virus entry. For human immunodeficiency virus type 1 (HIV-1), most viral isolates utilize the human CKRs CCR5 and/or CXCR4 as coreceptor. However, depending on their ability to interact with the viral glycoprotein Env, several other CKRs can facilitate HIV-1 entry. The cellular expression pattern of these receptors critically determines the tropism of HIV-1 in vivo and the concentration of CCR5 or CXCR4 on the cell surface can be rate-limiting for infection (Platt et al., 1998; Peters et al., 2004) .
HIV-1, HIV-2, and simian immunodeficiency virus (SIV) encode the accessory protein Nef, which is a key factor for lentiviral pathogenesis and disease progression following infection (Geyer et al., 2001; Greene and Peterlin, 2002) . Nef has no enzymatic activity, however, by acting as a multivalent adaptor protein it causes numerous host cell modulations, including the alteration of T-cell receptor signaling in order to prime infected Tcells for activation as well as the interference with intracellular vesicle trafficking (Arora et al., 2002; Fackler and Baur, 2002) . As one of its cardinal activities, HIV-1 Nef specifically modulates the surface expression of a rapidly growing number of cell surface receptors such as CD3, CD4, CD8, major histocompatibility complex class I (MHC-I), CD1a, CD1d, the invariant chain of immature MHC-II (CD74), mature MHC-II, DC-SIGN, mannose receptor, tumor necrosis factor, LIGHT, CD80, CD86, transferrin receptor, and hemochromatosis protein HFE (Garcia and Miller, 1991; Schwartz et al., 1996; Bell et al., 1998; Lama and Ware, 2000; Stumptner-Cuvelette et al., 2001; Sol-Foulon et al., 2002; Shinya et al., 2004; Chaudhry et al., 2005; Cho et al., 2005; Drakesmith et al., 2005; Madrid et al., 2005; Stove et al., 2005; Vigerust et al., 2005) . Nef's ability to serve as a sorting adapter is believed to be important for many of these receptor-modulating activities (Tolstrup et al., 2004) , although the molecular details are poorly understood. Despite the large number of receptors that are affected, Nef´s receptor cell surface modulation is not the consequence of generally altered plasma membrane turnover induced by this amino-terminally myristoylated protein. Abundant cell surface receptors such as the epidermal growth factor receptor are not affected by the expression of Nef (Madrid et al., 2005) . Furthermore, at least two distinct subsets of cell surface receptors exist that are targeted by Nef via two independent, genetically separable mechanisms (Mangasarian et al., 1999; Geyer et al., 2001) . Thus, discriminative mutations in Nef can completely abrogate downregulation of one receptor subset, while levels of other receptors are still drastically reduced. What governs this specificity and how these individual receptors are targeted by Nef is currently unknown. Recently, we demonstrated that expression of HIV Nef induces the reduction of surface-exposed CCR5 and CXCR4 (Michel et al., 2005) . The Nef-induced downregulation of CD4 and CCR5 independently and synergistically protected Nef-expressing target cells from HIV-1 superinfection due to an inhibited Env-mediated fusion of the viral with the target cell membrane (Michel et al., 2005) .
CXCR4 downregulation by Nef also impedes the agonist-induced chemotaxis of Jurkat Tcells (Hrecka et al., 2005) .
Here we asked whether Nef proteins from human and simian immunodeficiency virus target multiple members of the family of CKRs or whether the Nef activity is specific for CKRs that can function as coreceptors for HIV entry. Since the modulation of CKR cell surface expression is a key regulatory mechanism for the signaling activity, we were particularly interested in mapping viral and cellular determinants to shed light on the strategy utilized by Nef to affect the cell surface expression of this receptor family.
MATERIALS AND METHODS

Plasmids
Plasmids encoding the wild-type HIV-1 SF2 Nef or the mutants NefG2A, NefEDAA, NefLLAA, NefAxxA, and NefE4A, either bicistronically with GFP (from the pIRES2-EGFP vector; Clontech) or as a GFP-fusion protein (from the pEGFP-N1 vector; Clontech) have been reported (Krautkramer et al., 2004; Keppler et al., 2005; Michel et al., 2005) . To create the expression construct for Nef.RFP, the gene encoding for mRFP1 was amplified using pRSET B mRFP1 as template (kindly provided by Dr. Roger Tsien). The amplified mrfp1 gene was used to replace the egfp gene in the pEGFP-N1 vector by using two newly introduced 5' BamHI and 3' NotI sites. The resulting pmRFP-N1 expression vector has intermediate sequences between the MCS and the fluorescent gene ORF identical to those of the pEGFP-N1 vector as has been confirmed by sequence analysis. The HIV-1 SF2 nef gene was subsequently introduced via BglII and EcoRI resulting in the vector pmRFP-Nef. Correct expression of RFP and Nef.RFP was confirmed using confocal microscopy. Co-expression of Nef.GFP and Nef.RFP in CHO cells resulted in a pronounced co-localization of both proteins (for details please see Haller et al., submitted) .
Nef alleles from HIV-1 SF2 , HIV-1 NL4-3 , HIV-1 NA-7 , HIV-2 NEP , and SIV mac239 were expressed using the bicistronic GFP expression vector pCG (Greenberg et al., 1997; Lock et al., 1999; Michel et al., 2005) . The human CCR5 wild-type and the CCR5 mutants encoding the first 308 amino acids (CCR5Δ308) or the first 327 amino acids (CCR5Δ327) of CCR5 were amplified by PCR using the plasmid pCCR5hygro (Keppler et al., 2001) as template and appropriate primers that introduce a 5' BamHI site and a 3' stop codon immediately followed by a HindIII site. The obtained genes were first cloned in the vector pBK CMV (Stratagene) and then subcloned in the eukaryotic expression vectors pcDNA3.1/Hygro(-) and pcDNA3.1/Zeo(-) (Invitrogen). The CCR5R126N mutant was generated by amplifying an internal fragment of the CCR5 gene by PCR with primers that introduce the R126N mutation and allow the exchange of the wild-type CCR5 sequence with the mutant fragment in the CCR5-encoding pcDNA3.1/Hygro(-) vector via the internal ClaI and 3'XhoI site. The CCR5NAA mutant was generated by site-directed mutagenesis with the Quick-Change XL Kit (Stratagene) using the plasmid pcDNA3.1/Hygro(-) CCR5 as template and primers that introduce the mutations D125N, R126A, Y127A. The CCR5-SSSS/AAAA mutant (CCR5S4A) expression vector was kindly provided by Dr. Martin Oppermann (Universität Göttingen, Göttingen, Germany) (Kraft et al., 2001) . The expression plasmid pFX4, encoding CXCR4 wild-type was a gift from Dr. Mark Goldsmith. Dr. Stephen Peiper (Medical College of Georgia, Augusta, USA) kindly provided the expression plasmid for wild-type CCR3 and expression plasmids for mutated CXCR4 proteins with either a carboxy-terminal truncation after amino acid 316 together with alanine replacement mutations of T311A and S312A (CXCR4Δ316) or the mutations D133N, R134A, Y135A (CXCR4NAA) (Doranz et al., 1999) . The CXCR4R134N mutant was generated by site-directed mutagenesis with the Quick-Change XL Kit (Stratagene) using the plasmid pFX4 as template and primers that introduce the R134N mutation. The expression plasmid for CCR2 was kindly provided by Dr.
Mark Goldsmith. The expression vector for the VSV-G (Emi et al., 1991) was a kind gift from Dr. Jane Burns. The pBR HIV-1 NL4-3 IRES-GFP plasmids (∆nef, HIV-1 NA-7 nef or HIV-2 BEN nef, encoding replication-competent viruses with a nef-IRES-gfp element (Schindler et al., 2003) were kind gifts of Dr. Frank Kirchhoff (Universitätsklinikum Ulm, Ulm, Germany). The expression plasmid for the Rab11 protein fused to GFP (Rab11.GFP) was kindly provided by Dr. Serge Benichou (Madrid et al., 2005) .
Cells and Transfection
All cell lines were cultivated under standard conditions in Dulbecco's modified Eagle medium or RPMI1640 supplemented with 10% fetal bovine serum (FBS), 1% penicillinstreptomycin, and 1% L−glutamine (all from GIBCO). Stable transfectants for CHO hCD4/hCCR5, CHO hCXCR4, and HeLa-derived TZM cells, stably expressing CD4, CCR5, and an HIV LTR-driven β-galactosidase gene, have been reported (Keppler et al., 2001; Keppler et al., 2005) . CHO cells stably expressing HA-tagged human CCR1, CCR2, CCR3, CCR4, CCR5, CXCR1, CXCR2, or CXCR4 were kindly provided by Dr. Mark Marsh (University College London, London, UK) (Bron et al., 1997) . Human TZM hCCR5 high cells have been reported (Michel et al., 2005) HEK 293 cells were obtained from the ATCC.
Primary human CD4 T cells were purified and activated as described (Keppler et al., 2002) .
All cells were transiently transfected using calcium phosphate precipitation, Metafectene 
HIV Infections
Viral stocks were generated as described (Schindler et al., 2003) . HEK 293 cells, transiently transfected with a CCR3 expression plasmid 1 d earlier, were infected with replicationcompetent VSV-G pseudotyped HIV-1 NL4-3 IRES-GFP viruses (~ 200-1500 ng p24/8x10 5 cells) carrying either a defective nef gene (Δnef), a HIV-1 NA-7 nef, or a HIV-2 BEN nef allele. 22 h post infection, cells were harvested, stained for cell surface expressed CCR3 and subsequently fixed for 1.5 h in 2% paraformaldehyde/PBS. Analysis was performed by flow cytometry. Primary CD4 T cells were infected and analyzed for CXCR4 surface expression in principle as reported (Keppler et al., 2006) .
Confocal Immunofluorescence Microscopy
Transfected cells growing on coverslips were fixed with 4% paraformaldehyde and Fmin)]/(Fmax-Fmin)] as has been described for the related assay system based on the dye Fluo-3 (Lagane et al., 2005) .
Statistics
Statistical analysis was calculated with the software MS Excel 2003 using the unpaired Student's t-test. A result was considered significant when p < 0.05.
RESULTS
Cell Surface Levels of Eight Different 7-TM CKRs are Reduced by Nef
We recently observed that expression of HIV Nef reduces the cell surface level of the CKRs CCR5 and CXCR4 by up to 80% (Michel et al., 2005) . Here, we first explored whether the effect of Nef was specific for those CKRs that can serve as coreceptors for HIV entry. To this end, CHO cells, which stably express human CCR1, CCR2, CCR3, CCR4, CXCR1, or CXCR2 (Bron et al., 1997) , or CD4 in combination with CCR5 or CXCR4 (Michel et al., 2005) , were transiently transfected with bicistronic expression vectors encoding for GFP together with HIV-1 SF2 Nef (Nef/GFP) or GFP alone and analyzed 1 d later by flow cytometry ( Figure 1 ). Among these receptors, CCR2, CCR3, CCR5, and CXCR4, but not CCR1, CCR4, CXCR1, and CXCR2 have been reported to function as HIV-1 coreceptors (Berger et al., 1999) . For all CKRs analyzed, markedly reduced surface levels were observed in Nef/GFPexpressing cells. The Nef-specific downmodulation of CKRs ranged from 45% for CCR1 to 
CCR3 is Downregulated in HIV-infected Human Cells in a Nef-dependent Manner
Next, we explored whether one of the CC-CKRs newly identified as a target of transiently expressed HIV-1 Nef was also downregulated from the surface of HIV-infected human cells. Replication-competent HIV-1 NL4-3 -based reporter viruses, which carry either a nef IRES gfp element or a ∆nef IRES gfp element, allow for a flow cytometry-based assessment of Nef-dependent receptor changes in productively infected cells (Schindler et al., 2003; Keppler et al., 2005) . Importantly, we also observed a significant, Nef-dependent downregulation of CXCR4 in HIV-infected primary CD4 T cells, the degree of which was more pronounced for the HIV-2 BEN allele, reaching 82% ( Figure 2B ). Thus, besides CCR5 and CXCR4 ( (Hrecka et al., 2005; Michel et al., 2005) ; this study) the alternative HIV coreceptor CCR3 is downregulated from the surface of HIV-infected human cells in a Nef-dependent manner.
Downmodulation of 7-TM CKRs is a Conserved Function of Nef Proteins from HIV-1, HIV-2, and SIV
We then examined whether the ability to downmodulate multiple members of the CKR family is a characteristic of Nef proteins from different primate lentiviruses. CHO cell lines, stably expressing one of the CKRs or CD4, were transfected with bicistronic GFP expression vectors for Nef alleles from HIV-1 (SF2, NL4-3, NA-7), HIV-2 (NEP), or SIV (Mac239).
One day after transfection receptor levels were quantified by flow cytometry. All Nef alleles tested downmodulated the eight CC-and CXC-CKRs (Figure 3 ). The potency of the different alleles for reducing the cell surface levels of CD4 and, importantly, the CKRs, was fairly comparable. The Nef protein from HIV-1 NL4-3 was somewhat of an exception displaying weaker effects for CCR1, CCR2, CXCR1, CXCR2, and CXCR4. Thus, the ability to downmodulate surface levels of human CKRs is conserved among lentiviral Nef proteins and different CKRs apparently share a common determinant that is targeted by the viral protein.
Reduction of Cell Surface Levels of All Eight 7-TM CKRs Requires Identical Nef Motifs
To identify the molecular determinants in Nef required for downregulation of these CKRs, we tested several well-characterized mutants of the Nef protein from HIV-1 SF2 (Geyer et al., 2001; Michel et al., 2005) . (Geyer et al., 2001) , did not affect Nef's ability to downmodulate the CKRs, while both of these mutations, expectedly, rendered the Nef protein incapable of reducing CD4 cell surface levels. Conversely, alanine mutation of the src homology 3 (SH3)
binding motif of Nef (amino acids P 76 P 79 (NefAxxA)) or alanine mutation of the acidic cluster motif (amino acids E 66 E 67 E 68 E 69 (NefE4A)), required for the interaction with phosphofurin acidic cluster sorting protein 1 (PACS-1) and the AP-1/MHC-I complex (Piguet et al., 2000; Williams et al., 2005) , almost completely abrogated Nef's potential to reduce CKR cell surface levels. In contrast, the potency of these mutant Nef proteins to downmodulate CD4 was well preserved. In summary, downmodulation of CC-and CXC-CKRs by Nef is genetically separable from CD4 downmodulation, suggesting that these activities are mediated by the interaction with distinct cellular pathways.
Nef accelerates the endocytosis rate of several human cell surface receptors and this, at least partially, contributes to the Nef-mediated reduction of steady-state surface levels of CD4, MHC-I, and CCR5 (Aiken et al., 1994; Schwartz et al., 1996; Michel et al., 2005) . We also observed a moderate acceleration of CCR3 endocytosis in Nef/GFP-expressing CHO CCR3 cells relative to GFP-expressing or untransfected cells in an established kinetic endocytosis assay (supplementary Material and Methods and supplementary Figure 2 ). This effect was most pronounced at early time points of the kinetic (< 5 min). In particular at later time points, kinetic endocytosis assays can be affected by secondary effects of receptor recycling. Therefore, at this point we cannot exclude that Nef also targets CCR3 cell surface expression by inhibition of receptor recycling.
Nef Targets CCR1, CCR2, and CCR3 to a Perinuclear Compartment, where these
Receptors Accumulate and Partially Co-localize with Nef
Next, we explored the subcellular localization of three newly identified CKRs that are targeted by Nef, namely CCR1, CCR2, and CCR3. As judged by confocal microscopy and in line with the flow cytometric analyses presented in Figure 4 , cells expressing GFP fusion proteins of HIV-1 SF2 Nef typically exposed less CKRs on the cell surface than GFPexpressing control cells ( Figure 5A ). Importantly, cells expressing low to medium levels of Nef.GFP harbored prominent clusters of the CC-CKRs in the perinuclear region ( Figure 5A , white asterisks mark cells with perinuclear CKR accumulation). A significant fraction of Nef.GFP was also detected in this region and partially co-localized with all three receptors, as revealed in merged images ( Figure 5A ). Nef's perinuclear localization is not induced by the presence of human CKRs since it can also be observed in cells that do not express these receptors (supplementary Figure 3) . Accentuated CKR staining in the perinuclear region was occasionally seen also in GFP-transfected or untransfected control cells, suggesting that this perinuclear compartment may be involved also in the physiological life-cycle of these CKRs.
We then sought to define this compartment more closely by performing co-localization studies with established markers for the trans-Golgi network (TGN46; Figure 5B ) and for recycling endosomes (Rab11.GFP; Figure 5C ). Both of these compartment markers showed a considerable degree of co-localization with Nef and CKRs at the maximum resolution of this imaging technique. Furthermore, in cells expressing very high levels of Nef.GFP, the CKRs were detected neither on the cell surface, nor in perinuclear compartments (data not shown).
This observation is consistent with an accelerated Nef-induced receptor degradation as was previously seen for CCR5 in pulse-chase analyses (Michel et al., 2005) . In summary, Nef targets multiple CKRs to perinuclear compartments, where they accumulate and partially colocalize with the viral protein.
The Cytoplasmic Tail of CCR5 and CXCR4 is Dispensable for the Downmodulation by Nef
Since all CC-and CXC-CKRs tested were downmodulated by the identical motifs in the viral Nef protein, we sought to identify conserved motifs in CKRs that may serve as anchor points for this Nef activity. To this end, we analyzed different carboxy-terminal truncation and point mutants of the well-characterized CKR CCR5 that lack receptor elements critical for basal and ligand-induced internalization. Specifically, we included mutants with alanine replacement of the carboxy-terminal serine phosphorylation sites S 336 , S 377 , S 342 , and S 349 of CCR5 (CCR5S4A), then a deletion of the 25 carboxy-terminal CCR5 amino acids (CCR5Δ327), and finally, the additional deletion of carboxy-terminal amino acids disrupting the alternative di-leucine based receptor endocytosis motifs L 308 L 309 in CCR5 (CCR5Δ308) (Figure 6, A and B) . For CXCR4, a mutant was studied that lacks all carboxy-terminal amino acids after A 316 and has T 311 and S 312 replaced by alanine (CXCR4Δ316; (Doranz et al., 1999) ) and therefore is devoid of all potential serine/threonine phosphorylation sites and the alternative I 328 L 329 endocytosis motif in the carboxy-terminus (Signoret et al., 1998) ( Figure   6 , A and B).
To evaluate the ability of Nef to downmodulate the carboxy-terminal truncated CKRs, we transiently co-expressed wild-type or mutant CKRs together with either Nef/GFP or GFP and, subsequently, quantified levels of surface-exposed receptors by flow cytometry. In these co-transfection experiments, the MFI for surface expression of each CKR mutant on cells with high level GFP expression was set to 100% ( Figure 7 , A and C; FACS gate indicated in dot plots). Remarkably, all CCR5 mutants, including the CCR5Δ308 mutant, were downmodulated by Nef as efficiently as the wild-type CCR5 protein, with remaining surface levels ranging from 9-34% ( Figure 7 , A and Β). As an informative control, steady-state cell surface levels of the CCR5Δ308 mutant were completely unaffected by treatment with the natural ligand CCL5 (regulated upon activation, normal T-cell expressed and secreted, RANTES) (data not shown), confirming a previous report (Kraft et al., 2001) . In contrast, surface-exposure of CCR5 wild-type, CCR5Δ327, and CCR5-4SA mutants was markedly reduced by CCL5 treatment (data not shown and (Kraft et al., 2001) ). Of note, the CCR5Δ308 mutant was expressed ~5-10-times less efficiently on the surface compared to CCR5 wildtype. Similarly, the CXCR4Δ316 mutant was downmodulated by Nef at least as efficiently as CXCR4 wild-type ( Figure 7 , C and D). Thus, the CCR5 and CXCR4 carboxy-termini, which harbor the classical and highly conserved motifs that are critical for basal and ligand-induced receptor desensitization and endocytosis, are dispensable for the Nef-mediated reduction of CKR surface-exposure.
The DRY motif of CXCR4 is a Central Element for the Nef-induced Modulation of Cell Surface Expression
Sequence alignment of the CKRs targeted by Nef highlights that in addition to the carboxy-terminal endocytosis motifs, only the DRY motif in the second intracellular loop, which plays an important role in GPCR activation and signaling via heterotrimeric G-proteins (Scheer et al., 1997; Rasmussen et al., 1999; Scheer et al., 2000; Seifert and Wenzel-Seifert, 2003) , is highly conserved among all receptors analyzed herein. We therefore explored the importance of this DRY motif for the Nef-induced downregulation by investigating a CXCR4
protein with its DRY motif triple-mutated to Asn-Ala-Ala (CXCR4NAA) (Doranz et al., 1999) . CXCR4NAA is able to bind CXCL12 (stromal cell-derived factor-1α, SDF-1α) and can serve as HIV coreceptor. However, CXCR4NAA has been reported to be markedly impaired in CXCL12-mediated signaling and calcium mobilization (Doranz et al., 1999) .
CXCR4NAA is generally expressed less efficiently on the cell surface as compared to CXCR4 wild-type ( Figure 8A and (Doranz et al., 1999) ).
Using the above described co-transfection assay (Figure 7) , we made the astounding observation that expression of Nef/GFP induced a 3.5-fold upregulation of surface-exposed CXCR4NAA receptors, while CXCR4 wild-type receptors were, expectedly, markedly downregulated in the presence of the viral protein ( Figure 8, A and B) . In contrast, CXCL12 downregulated both the wild-type receptor and the NAA mutant with comparable efficiency ( Figure 8C ), demonstrating a preserved capacity of the CXCR4NAA mutant for ligandinduced internalization and excluding a gross deficiency of the integrity and membrane localization of this receptor mutant. We also constructed CCR2NAA, CCR3NAA, and CCR5NAA mutants, the poor cell surface expression of which unfortunately precluded further analyses (data not shown). Thus, at least for CXCR4, the full integrity of the DRY motif, which is highly conserved among CKRs, critically determined the susceptibility of the receptor to Nef-mediated up-or downregulation.
Nef-induced Downregulation of CCR5 and CXCR4 from the Cell Surface Does Not
Depend on the Gα i -mediated Signaling via Heterotrimeric G-proteins
Mutation of the DRY motif severely reduces or abolishes the capacity of CKRs, including CXCR4 and CCR5, to bind to and signal through the Gα i -subunit of the heterotrimeric G-protein (Doranz et al., 1999; Lagane et al., 2005) . To examine the role of with Gα i -mediated signaling did not affect the Nef-induced CKR downregulation.
Next, we investigated the role of the DRY motif integrity for the Nef-induced CKR downregulation with respect to its role in receptor signaling in more detail. For CCR5, a mutant protein with a single mutation of the DRY box (CCR5R126N) was generated, that preserves the well conserved arginine-surrounding aspartic acid and tyrosine residues of the DRY motif, but is still deficient in constitutive and ligand-induced Gα i -protein binding and signaling (Lagane et al., 2005) . In addition, a corresponding DRY motif mutant of CXCR4 was constructed (CXCR4R134N). Both of these CKR mutant proteins were downregulated by Nef with efficiencies comparable to the wild-type receptors (Figure 10 ). In summary, these results highlight that the DRY motif is critically involved in the Nef-mediated reduction of CXCR4 cell surface levels, but that the DRY motif requirement is apparently not related to its role in facilitating conformational changes of the CKR leading to G-protein coupling and subsequent signaling via Gα i -subunits. The importance of the DRY motif for the Nefmediated CXCR4 downregulation only becomes apparent when less conservative triplemutations are present. This suggests a critical role of the DRY motif in the CKR biology beyond G-protein coupling and signaling that is particularly important for the fate of the receptor in the presence of HIV Nef.
DISCUSSION
This study demonstrates that lentiviral Nef proteins efficiently reduce the cell surface levels of multiple members of the family of G-protein coupled CC-and CXC-CKRs. Nef apparently utilizes a non-classical, yet general pathway to regulate the surface exposure of
CKRs. This pathway does not require carboxy-terminal CKR motifs necessary for agonistdriven receptor endocytosis but, at least for CXCR4, depends on the DRY box motif in the second intracellular loop. Surprisingly, the DRY box dependence was unrelated to CKR G-protein coupling and signaling through the Gα i -subunit; two activities previously established to be controlled by CKR conformational changes that are governed by this motif.
The versatile functions of CKRs in leukocyte biology require a precise regulation of signal initiation and subsequent desensitization following ligand engagement. The modulation of the cell surface density is a key mechanism regulating the signaling activity of all CKRs (Neel et al., 2005) . The CKRs analyzed in this study share only 24-39% sequence homology and possess many individual characteristics, i.e. bind specific subsets of ligands, mediate distinct intracellular signals, and have individual, cell type-dependent characteristics concerning receptor endocytosis, recycling, and degradation (Murphy et al., 2000; Johnson et al., 2004; Neel et al., 2005) . The fact that all of these diverse CKRs were targeted with comparable efficacy by the identical motifs in Nef from HIV-1 SF2 suggests that a universal, possibly indirect mechanism may be employed by the viral protein. Regarding the motifs in Nef, the acidic cluster motif (amino acids E 66 E 67 E 68 E 69 ), which is required for interaction with the PACS-1 sorting adapter, and the Nef motif for binding to SH3 domain-containing proteins (amino acids P 73 xxP 76 xxP 79 xxP 82 ) were both mandatory elements for the surface reduction of CKRs. Interestingly, Nef utilizes the identical motifs to reduce the surface expression of structurally unrelated MHC-I molecules. For Nef's effect on MHC-I, the acidic cluster motif, besides mediating the PACS-1 interaction, is also required for interaction with the MHC-I cytoplasmic tail (Williams et al., 2005) . In contrast, motifs in the flexible loop region of Nef (Peterlin and Trono, 2003) . However, of the currently more than 20 cell surface receptors reported to be affected by Nef, only low-affinity interactions were demonstrated for two receptors, namely CD4 and MHC-I, in some studies (Williams et al., 2002; Cluet et al., 2005) . In line with the scarcity of reported interactions, we did not find evidence for a physical association of Nef and CCR5 in co-immunoprecipitation studies from CHO cells (data not shown). In light of the rapidly growing list of only distantly related receptor molecules, the surface exposure of which is modulated by Nef, a more general mode of action, that may not necessarily require physical interaction, seems likely. Recently, a generalized alteration of endocytic vesicle trafficking induced by Nef was proposed as a mechanism for affecting cell surface receptors, including the transferrin receptor (Madrid et al., 2005) . infection and found comparable expression levels of the viral protein (Keppler et al., 2006) .
Our kinetic endocytosis assays and localization studies revealed that Nef only moderately accelerated the rate of CKR endocytosis. Since a robust reduction of CCR3 and CCR5 steady-state cell surface levels was observed already 4 hours post-transfection of CHO cells with Nef.GFP expression plasmids (data not shown), it seems likely that mechanisms other than accelerated endocytosis of surface-exposed receptors contribute to this Nefmediated phenotype. In the case of MHC-I (Blagoveshchenskaya et al., 2002; Kasper and Collins, 2003) , these include Nef-mediated disturbance of receptor recycling to the cell surface and diversion of newly synthesized molecules during anterograde transport.
Conceivably, the sum of such interferences may result in the net reduction of cell surface CKR levels and the pronounced perinuclear accumulation observed at steady-state in Nefexpressing cells. Irrespective of the sorting mechanism employed, our previous results obtained for CCR5 (Michel et al., 2005) and the intracellular localization studies presented herein suggest CKR degradation as a possible consequence of Nef-mediated perturbance of CKR transport pathways. Of note, the Nef-mediated CKR cell surface level reduction does apparently not involve an interference with CKR de novo synthesis since CCR5-transgene expression was not affected in Nef-expressing human TZM cells that display a profound CCR5 downmodulation (Michel et al., 2005) .
It is conceivable that Nef acts at the early endosomal compartment (Madrid et al., 2005) , through which CKRs traffic following internalization, irrespective of their preferred endocytosis route (Neel et al., 2005) , and thereby mediates its effect on CKR cell surface expression. Nef possibly perturbs the rapid recycling of CKRs to the cell surface and reroutes the receptors to a perinuclear compartment. This compartment may be related to the slow recycling compartment that was found to be involved in normal trafficking of some CKRs (Neel et al., 2005) , as supported by our co-localisation of Nef and CCR3 with Rab11.GFP.
However, we also found a significant co-localisation of the trans golgi network marker TGN46 with CCR5 in Nef-expressing TZM cells, in line with a previous report on the localization of MHC-I in Nef-expressing HeLa-CD4 and A7 cells (Blagoveshchenskaya et al., 2002) . In our opinion the resolution of confocal microscopy does not allow a clear distinction between these and other closely adjacent perinuclear compartments. The nature of the perinuclear accumulation of CKRs and MHC-I in Nef-expressing cells still remains to be clarified in future studies.
Our data show that lentiviral Nef proteins have evolved a general strategy to affect the cell surface levels of CKRs. Importantly, Nef-specific CKR downregulation occurs in HIVinfected human cells, including primary human T-cells (Michel et al., 2005) . The existence of a mechanism that targets such a broad class of cell surface receptors may reflect the need of HIV to downmodulate both of the divergent major entry coreceptors CCR5 and CXCR4 to efficiently protect productively infected cells from superinfection ( (Michel et al., 2005) and data not shown). However, the newly found Nef activity of downregulation of at least eight different CKRs is not restricted to those receptors which function as HIV coreceptors.
Conceivably, and as reported for CXCR4 (Hrecka et al., 2005) , downmodulation of these receptors may profoundly alter the responsiveness of Nef-expressing cells to chemokine attractants. The reduced CKR expression on these cells may disturb the coordinated action of host immune responses against virus-infected cells (Esche et al., 2005) , and this may assist the immune evasion of HIV.
At present, there is only limited knowledge about the regulation of the internalization rate and intracellular trafficking of individual CKRs under physiological conditions in the absence or presence of ligand. In general, parameters known to influence receptor endocytosis include the type and concentration of ligand, composition of the CKR cytoplasmic tail, receptor phosphorylation status, and abundance of endocytosis-associated adaptor molecules in the cytoplasm (Neel et al., 2005) . The mechanism by which lentiviral Nef proteins reduce CKR cell surface exposure differs by several criteria from known pathways utilized by individual CKRs for internalization and intracellular trafficking. First, the Nef-induced CCR5
and CXCR4 downregulation is completely independent of agonist-engagement. This contrasts the situation under physiological conditions, during which chemokine ligands are the main trigger for CKR cell surface level reduction that is primarily mediated by an accelerated clathrin-mediated receptor endocytosis. A lipid raft/caveolae-associated pathway has also been proposed as an alternative internalization route for some CKRs, including CCR5 and CXCR4, in this context (Mueller et al., 2002; Venkatesan et al., 2003; Mariani et al., 2004) .
However, this alternative pathway seems to be restricted to certain cell types and the evaluation of its importance in vivo has so far not been possible (Signoret et al., 2000; Venkatesan et al., 2003; Neel et al., 2005; Signoret et al., 2005) . containing GPCRs may also be a target for Nef-mediated downregulation from the cell surface and this would be an interesting extension of our present work. Recent studies indicate that the DRY motifs of some CKRs like CCR2, CCR5, and CXCR4, besides G-protein coupling, act as docking sites for additional cellular adaptor proteins involved in signaling and endocytosis, including JAK2 kinase and β-arrestins (Mellado et al., 1998; Roland et al., 2003; Lagane et al., 2005) . Future studies will need to explore their potential role in the modulation of CKR cell surface expression by Nef.
Finally, Nef is the first broad-spectrum modulator of CC-and CXC-CKRs cell surface levels since it affects the cell surface expression of at least eight rather diverse CKRs with comparable efficiencies and diverts these receptors from their individual intracellular trafficking pathway to a probably common perinuclear compartment. This is in contrast to the individual cell surface turn-over rates and the multifaceted internalization and intracellular trafficking pathways of different CKRs under physiological conditions (Neel et al., 2005) .
The apparently non-classical mechanism Nef employs to affect CKR internalization and intracellular trafficking makes this viral protein a valuable tool for future studies on the complex regulation of CKR signaling activity and/or cell surface expression. Furthermore, understanding the impact of Nef's effect on the CKR family, that critically controls many aspects of leukocyte biology in the host immune system, may help to gain insight into Nef's key role in HIV replication and pathogenesis. wild-type together with bicistronic expression plasmids for GFP or Nef/GFP. Cell surface levels of mutant and wild-type CKRs were analyzed in principle as described in the legend to 
